Down -6.19% in 4 Weeks, Here's Why Takeda Pharmaceutical Co. (TAK) Looks Ripe for a Turnaround

Yahoo FinanceApr 29 21:35

EU Panel Backs Approval of Takeda's Colorectal Cancer Drug

Takeda Pharmaceutical (TKD.F) was notified that the European Medicines Agency's Committee for Medicinal Products for Human Use recommended the approval of fruquintinib to treat metastatic colorectal c

MT NewswiresApr 26 23:39

European Medicines Agency Committee Backs Approval of Takeda's Fruquintinib to Treat Colorectal Cancer

Takeda Pharmaceutical (TAK) has been notified that the European Medicines Agency's Committee for Medicinal Products for Human Use is recommending the approval of fruquintinib to treat adults with prev

MT NewswiresApr 26 22:06

Down -5.9% in 4 Weeks, Here's Why Takeda Pharmaceutical Co. (TAK) Looks Ripe for a Turnaround

Yahoo FinanceApr 26 21:35

Takeda Receives Positive CHMP Opinion For Fruquintinib In Previously Treated Metastatic Colorectal Cancer

− If Approved in the European Union, Fruquintinib Will Be the First Novel Targeted Therapy for Metastatic Colorectal Cancer Regardless of Biomarker Status in Over a Decade− Positive Opinion Based on R

BenzingaApr 26 20:32

Express News | Takeda Receives Positive Chmp Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer

BreakingsApr 26 20:30